Actively Recruiting
Brugada Syndrome Substrate Characterization and Ablation
Led by Maria Cecilia Hospital · Updated on 2025-08-15
20
Participants Needed
1
Research Sites
177 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Independent, single center, prospective study, to evaluate the efficacy, in consecutive BrS patients undergoing catheter ablation, at medium-long term follow-up after epicardial substrate homogenization. The target area is defined collecting signals using high density and high resolution mapping with equi-spaced electrode array. The ablation of abnormal fragmented prolonged low-frequency ventricular electrograms is performed by contact force catheter.
CONDITIONS
Official Title
Brugada Syndrome Substrate Characterization and Ablation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Symptomatic patients diagnosed with Brugada Syndrome ECG pattern types 1 and 2, spontaneous or after Ajmaline test, with an implanted ICD
- At least one documented episode of ventricular tachycardia or ventricular fibrillation in the 12 months before enrollment
- Eligible for ablation with 3D high-density mapping system as per national guidelines and medical decision
- Adults able to provide written informed consent
You will not qualify if you...
- Unable to provide written informed consent
- Unable to attend future follow-up visits
- Life expectancy less than 12 months as judged by a doctor
- Cardiac ablation within 90 days before enrollment
- Unresolved adverse events from any invasive procedure
- Women who are pregnant or planning pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maria Cecilia Hospital
Cotignola, Ravenna, Italy, 48033
Actively Recruiting
Research Team
S
Saverio Iacopino, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here